FrancophonIA/ELRC3.0 huggingface dataset:
English: GONAL-f, in combination with LH, has also been studied in 38 women with severe LH and FSH deficiency, and in combination with hCG in 19 men with hypogonadotrophic hypogonadism.
Maltese: GONAL-f, f'kombinazzjoni ma' LH, ġie studjat ukoll fi 38 mara b'nuqqas sever ta' LH u FSH u f'kombinazzjoni ma' hCG f'19-il raġel b'ipogonadiżmu ipogonadotrofiku.
English: GONAL-f was also as effective as human FSH at stimulating the ovaries during assisted reproductive techniques.
Maltese: GONAL-f kien effikaċi wkoll bħall-FSH uman fl-istimulazzjoni tal-ovarji matul tekniki ta' riproduzzjoni assistita.
English: How has GONAL-f been studied?
Maltese: Kif ġie studjat GONAL-f?
English: GONAL-f should not be used in people who may be hypersensitive (allergic) to follitropin alfa, FSH, or any of the other ingredients.
Maltese: GONAL-f ma għandux jintuża f'nies li jistgħu jkunu sensittivi żżejjed (allerġiċi) għal follitropin alfa, FSH, jew għal xi sustanza oħra tiegħu.
English: In women, ovarian cysts (sacs of fluid within the ovaries) and headache are also seen in more than 1 patient in 10.
Maltese: Fin-nisa, ċesti fl-ovarji (boroż ta' fluwidi fl-ovarji) u uġigħ ta' ras jidhru wkoll f'aktar minn pazjent 1 minn kull 10.
English: GONAL-f is given together with a medicine containing LH to stimulate the eggs to mature in the ovaries;
Maltese: Qabel, l-FSH użat fil-mediċini kien jiġi estratt mill-urina.
English: It is available as round tablets (blue: 0.5 mg; yellow: 1 mg; peach: 2 mg).
Maltese: Huwa disponibbli f'pilloli tondi (blu: 0.5 mg; sofor: 1 mg; lewn il-ħawħ:
English: Repaglinide Teva repaglinide EPAR summary for the public
Maltese: Repaglinide Teva repaglinide Sommarju tal-EPAR għall-pubbliku
English: Repaglinide Teva is a medicine that contains the active substance repaglinide.
Maltese: Repaglinide Teva huwa mediċina li fiha s-sustanza attiva repaglinide.
English: This summary was last updated in 06-2009.
Maltese: Is-sommarju ġie aġġornat l-aħħar fi: 06-2009.
English: The European Commission granted a marketing authorisation valid throughout the European Union for Repaglinide Teva to Teva Pharma B.V. on 29 June 2009.
Maltese: Il-Kummissjoni Ewropea tat awtorizzazzjoni għat-tqegħid fis-suq valida fl-Unjoni Ewropea kollha għal Repaglinide Teva lil Teva Pharma B.V. fid-29 ta' Ġunju 2009.
English: What are the benefit and risk of Repaglinide Teva?
Maltese: X'inhu l-benefiċċju u r-riskju ta' Repaglinide Teva?
English: This means that Repaglinide Teva is similar to a ‘reference medicine' already authorised in the European Union (EU) called NovoNorm.
Maltese: Repaglinide Teva huwa ‘mediċina ġenerika' Dan ifisser li Repaglinide Teva huwa simili għal ‘mediċina ta' referenza' diġà awtorizzata fl-Unjoni Ewropea (UE) bl-isem NovoNorm.
English: Because Repaglinide Teva is a generic medicine, studies have been limited to tests to determine that it is bioequivalent to the reference medicine (this means that the two medicines produce the same levels of the active substance in the body).
Maltese: Minħabba li Nimvastid huwa mediċina ġenerika, l-istudji ġew limitati għal testijiet biex jiġi determinat li huwa bijoekwivalenti għall-mediċina ta' referenza (jiġifieri li ż-żewġ mediċini jipproduċu l-istess livelli ta' sustanza attiva fil-ġisem).
English: If patients are transferred from another anti-diabetes medicine, the recommended starting dose is 1 mg.
Maltese: Jekk pazjenti jibdlu minn mediċini oħra ta' kontra d-dijabete, id-doża tal-bidu rakkomandata hija 1 mg.
English: Repaglinide Teva is taken before meals, normally up to 15 minutes before each main meal.
Maltese: Repaglinide Teva jittieħed qabel l-ikel, normalment kwarta qabel kull ikla prinċipali.
English: Why has Repaglinide Teva been approved?
Maltese: Għaliex ġie approvat Repaglinide Teva?
English: What is Repaglinide Teva?
Maltese: Kif tintuża Repaglinide Teva?
English: Repaglinide Teva helps the pancreas to produce more insulin at mealtimes and is used to control type 2 diabetes.
Maltese: Repaglinide Teva jgħin lill-frixa tipproduċi iktar insulina f'ħin l-ikel u jintuża biex jikkontrolla dijabete tat-tip 2.
English: Repaglinide Teva is used in patients who have type 2 diabetes (non-insulin-dependent diabetes).
Maltese: Repaglinide Teva jintuża fit-trattament ta' pazjenti adulti li jbatu mid-dijabete tat-tip 2 (dijabete mhux dipendenti mill-insulina).
English: Other information about Repaglinide Teva:
Maltese: Aktar tagħrif ieħor dwar Repaglinide Teva:
English: It is used together with diet and exercise to lower blood glucose (sugar) levels in patients whose hyperglycaemia (high blood glucose levels) cannot be controlled by diet, weight reduction and exercise.
Maltese: Jintuża flimkien ma' dieta u eżerċizzju biex ibaxxi l-livell ta' glukożju (zokkor) fid-demm f'pazjenti li jkollhom ipergliċemija (livelli għoljin ta' glukożju fid-demm) li ma tkunx tista' tiġi kontrollata minn dieta, tnaqqis fil-piż u eżerċizzju.
English: The Committee for Medicinal Products for Human Use (CHMP) concluded that, in accordance with EU requirements, Repaglinide Teva has been shown to have comparable quality and to be bioequivalent to NovoNorm.
Maltese: Il-Kumitat għall-Prodotti Mediċinali għall-Użu mill-Bniedem (CHMP) ikkonkluda li, b'mod konformi mar-rekwiżiti tal-UE, Repaglinide Teva wera li għandu kwalità komparabbli ma' u huwa bijoekwivalenti għal NovoNorm.
English: Because Repaglinide Teva is a generic medicine and is bioequivalent to the reference medicine, its benefit and risk are taken as being the same as those of the reference medicine.
Maltese: Minħabba li Repaglinide Teva huwa mediċina ġenerika u huwa bijoekwivalenti għall-mediċini ta' referenza, il-benefiċċju u r-riskju tiegħu huma meqjusa li huma l-istess bħal dawk tal-mediċina ta' referenza.
English: Repaglinide Teva may also be used with metformin (another anti-diabetes medicine) in type 2 diabetes patients whose blood glucose levels are not satisfactorily controlled on metformin alone.
Maltese: Repaglinide Teva jista' jintuża wkoll ma' metformin (mediċina oħra kontra d-dijabete) f'pazjenti b'dijabete tat-tip 2 li jkollhom livelli ta' glukożju fid-demm li ma jkunux ikkontrollati biżżejjed bl-użu ta' metformin waħdu.
English: Therefore, the CHMP's view was that, as for NovoNorm, the benefit outweighs the identified risk.
Maltese: Għaldaqstant, il-fehma tas-CHMP kienet li, bħal fil-każ ta' NovoNorm, il-benefiċċji huma akbar mir-riskji identifikati.
English: How is Repaglinide Teva used?
Maltese: Kif jaħdem Repaglinide Teva?
English: The full EPAR for Aerius can be found on the Agency's website: ema.europa.eu/Find medicine/Human medicines/European Public Assessment Reports.
Maltese: ema.europa.eu/Find medicine/Human medicines/European Public Assessment Reports.
English: EPAR summary for the public desloratadine
Maltese: Sommarju tal-EPAR għall-pubbliku desloratadine
English: The active substance in Aerius, desloratadine, is an antihistamine.
Maltese: Is-sustanza attiva f'Aerius, id-desloratadine, hija sustanza anti-istaminika.
English: Other information about Aerius
Maltese: Informazzjoni oħra dwar Aerius
English: This is a summary of the European public assessment report (EPAR) for Aerius.
Maltese: Dan id-dokument huwa sommarju tar-Rapport Pubbliku Ewropew ta' Valutazzjoni (EPAR) għal Aerius.
English: It is available as a 5 mg tablet, 2.5 mg and 5 mg orodispersible tablets (tablets that dissolve in the mouth), a 0.5 mg/ml syrup and a 0.5 mg/ml oral solution.
Maltese: Huwa disponibbli bħala pillola ta' 5 mg, bħala pilloli li jinħallu fil-ħalq ta' 2.5mg u ta' 5 mg (pilloli li jiddewbu fil-ħalq), mistura ta' 0.5 mg/ml u soluzzjoni orali ta' 0.5 mg/ml.
English: Aerius is a medicine containing the active substance desloratadine.
Maltese: Aerius huwa mediċina li fiha s-sustanza attiva desloratadine.
English: In the two studies in urticaria, the decrease in symptom score after six weeks of treatment with Aerius was 58 and 67%, compared with 40 and 33% in placebo-treated patients.
Maltese: Fiż-żewġ studji dwar l-urtikarja, wara sitt ġimgħat ta' trattament b'Aerius, it-tnaqqis fil-punteġġ tas-sintomi kien 58 u 67%, meta mqabbel ma' 40 u 33% f'pazjenti li kienu qed jieħdu l-plaċebo.
English: What is Aerius?
Maltese: X'inhu Aerius?
English: The European Commission granted a marketing authorisation valid throughout the European Union for Aerius on 15 January 2001.
Maltese: Il-Kummissjoni Ewropea tat awtorizzazzjoni għat-tqegħid fis-suq valida fl-Unjoni Ewropea kollha għal Aerius fil-15 ta' Jannar 2001.
English: Aerius is used to relieve the symptoms of allergic rhinitis (inflammation of the nasal passages caused by an allergy, for example, hay fever or allergy to dust mites) or urticaria (a skin condition caused by an allergy, with symptoms including itching and hives).
Maltese: Aerius jintuża biex itaffi s-sintomi tar-rinite allerġika (infjammazzjoni tal-passaġġi nażali kkawżata minn allerġija, pereżempju riħ tal-ħuxlief (hay fever) jew allerġija għal akari tat-trab (dust mites)) jew urtikarja (kundizzjoni fil-ġilda kkawżata minn allerġija, b'sintomi li jinkludu ħakk u ħorriqija).
English: Aerius has also been studied in 416 patients with urticaria.
Maltese: Aerius ġie studjat ukoll f'416-il pazjent b'urtikarja.
English: Why has Aerius been approved?
Maltese: Għaliex ġie approvat Aerius?
English: In allergic rhinitis, looking at the results of all studies taken together, two weeks of treatment with 5 mg Aerius led to an average decrease in symptom score of 25 to 32%, compared with a decrease of 12 to 26% in the patients receiving placebo.
Maltese: Fir-rinite allerġika, ir-riżultati tal-istudji kollha meħuda flimkien urew li ġimagħtejn ta' trattament b'Aerius 5mg wassal għal tnaqqis medju fil-punteġġ tas-sintomi ta' bejn 25 u 32%, meta mqabbel ma' tnaqqis ta' bejn 12 u 26% fil-pazjenti li kienu qed jingħataw il-plaċebo.
English: What is the risk associated with Aerius?
Maltese: X'inhu r-riskju assoċjat ma' Aerius?
English: Aerius has been studied in a total of eight studies involving about 4,800 adult and adolescent patients with allergic rhinitis (including four studies in seasonal allergic rhinitis, and two studies in patients who also had asthma).
Maltese: B'kollox saru tmien studji fuq Aerius li fihom ħadu sehem madwar 4,800 pazjent adult u adoloxxent bir-rinite allerġika (li kienu jinkludu erba' studji dwar rinite allerġika staġjonali u żewġ studji fuq pazjenti li kellhom ukoll l-ażżma).
English: How has Aerius been studied?
Maltese: Kif ġie studjat Aerius?
English: The CHMP decided that Aerius's benefits are greater than its risks for the relief of symptoms associated with allergic rhinitis or urticaria and recommended that it be given marketing authorisation.
Maltese: Is-CHMP iddeċieda li l-benefiċċji ta' Aerius huma akbar mir-riskji tiegħu fis-serħan mis-sintomi assoċjati mar-rinite allerġika jew mal-urtikarja u rrakkomanda li jingħata awtorizzazzjoni għat-tqegħid fis-suq.
English: It works by blocking the receptors to which histamine, a substance in the body that causes allergic symptoms, normally attaches itself.
Maltese: Taħdem billi timblokka rriċetturi li normalment teħel fuqhom l-istamina, sustanza fil-ġisem li tikkawża sintomi allerġiċi.
English: For the full list of all side effects reported with Aerius, see the package leaflet.
Maltese: Għal-lista sħiħa tal-effetti sekondarji kollha rrappurtati b'Aerius, ara l-fuljett ta' tagħrif.
English: -1- - Synthetic peptide analogue of GnRF conjugated to a carrier protein of min. 300 µg per 2 ml dose
Maltese: -1- Peptajd sintetiku jixbaħ lil GnRF ikkonjugat ma' proteina b'min. ta' 300 µg f'kull doża ta' 2 ml
English: EU (MA) number
Maltese: Numru tal-UE Isem tal
English: Pharmaceutical form
Maltese: Saħħa Għamla Farmaċewtika
English: Route of administration
Maltese: Metodu ta' Amministra zzjoni
English: Invented name
Maltese: Prodott
English: Strengt h
Maltese: Perjodu ta'
English: Aluminium/aluminium blisters (PA/Al/PVC/Al or PA/PA/Al/PVC/Al).
Maltese: Folji tal-aluminju/aluminju (PA/PA/Al/PVC/Al).
English: 14 tablets 28 tablets 56 tablets 98 tablets
Maltese: 14-il pillola 28 pillola 56 pillola 98 pillola
English: Micardis contains sorbitol.
Maltese: Micardis fih sorbitol.
English: 10 rue Colonel Charbonneaux 51100 Reims
Maltese: Delpharm Reims S.A.S. 10 Rue Colonel Charbonneaux 51100
English: Possible side effects of Micardis
Maltese: Effetti sekondarji possibbli ta' Micardis
English: Rottendorf Pharma GmbH Ostenfelder Straße 51 - 61 59320 Ennigerloh Germany
Maltese: Rottendorf Pharma GmbH Ostenfelder Straße 51 - 61 59320 Ennigerloh Il-Ġermanja
English: 14 tablets 28 tablets 56 tablets 98 tablets 28 x 1 tablets 84 tablets 30 x 1 tablets 90 x 1 tablets
Maltese: 14-il pillola 28 pillola 56 pillola 98 pillola 28 x 1 pilloli 84 pillola 30 x 1 pillola 90 x 1 pillola
English: Boehringer Ingelheim, Unipessoal, Lda.
Maltese: Boehringer Ingelheim, Unipressoal, Lda.
English: Investigations Uncommon: Rare:
Maltese: Mhux komuni: Rari:
English: Micardis 20 mg tablets Pack sizes: Blister with 14, 28, 56 or 98 tablets.
Maltese: Micardis 20 mg pilloli Daqsijiet tal-pakketti: Folja b'14, 28, 56 jew 98 pillola.
English: See also information under the heading “Do not take Micardis”.
Maltese: Ara wkoll l-informazzjoni taħt t-titlu “Tiħux Micardis”.
English: Date of first authorisation: 16 December 1998 Date of last renewal: 16 December 2008
Maltese: Data tal-aħħar tiġdid: 16 ta' Diċembru, 2008
English: Telmisartan was found to be similarly effective to ramipril in the pre-specified secondary endpoint of cardiovascular death, non-fatal myocardial infarction, and non-fatal stroke [0.99 (97.5 % CI 0.901.08), p (non-inferiority) = 0.0004], the primary endpoint in the reference study HOPE (The Heart Outcomes Prevention Evaluation Study), which had investigated the effect of ramipril vs. placebo.
Maltese: Instab li telmisartan kien effettiv bl-istess mod bħal ramipril fir-riżultat aħħari sekondarju speċifikat minn qabel ta' mewt kardjovaskulari, infart mijokardijaku mhux fatali, u puplesija mhux fatali [0.99 (97.5% CI 0.90 - 1.08), p (non-inferjorità) = 0.0004], ir-riżultat aħħari primarju fl-istudju ta' referenza HOPE (The Heart Outcomes Prevention Evaluation Study), li kien investiga l-effett ta' ramipril vs. plaċebo.
English: Micardis is available in blister packs containing 14, 28, 56 or 98 tablets.
Maltese: Micardis hu disponibbli f'pakketti b'folji ta' 14, 28, 56 u 98 pillola.
English: Povidone (K25) Meglumine Sodium hydroxide
Maltese: Povidone (K25) Meglumine Sodium hydroxide Sorbitol (E420) Magnesium stearate
English: Patients with rare hereditary problems of fructose intolerance should not take Micardis.
Maltese: Pazjenti li għandhom problemi ereditarji rari ta' intolleranza għall-fructose m'għandhomx jieħdu Micardis.
English: Other medicines and Micardis
Maltese: Mediċini oħra u Micardis
English: MON TUE WED THU FRI SAT SUN
Maltese: Kura ta' pressjoni tad-demm għolja essenzjali
English: INFORMATION IN BRAILLE Micardis 40 mg
Maltese: INFORMAZZJONI BIL-BRAILLE Micardis 40 mg
English: Do not take Micardis
Maltese: Tiħux Micardis
English: Back pain (e.g. sciatica), muscle spasms, myalgia Arthralgia, pain in extremity, tendon pain (tendinitis like symptoms)
Maltese: Uġigħ fid-dahar (eż. xjatika), spażmi tal-muskoli, mijalġja Artralġja, uġigħ fl-estremitajiet, uġigħ fit-tendini (sintomi qishom tendinite)
English: Serious adverse drug reactions include anaphylactic reaction and angioedema which may occur rarely (≥1/10,000 to <1/1,000) , and acute renal failure.
Maltese: Reazzjonijiet avversi serji tal-mediċina jinkludu reazzjoni anafilattika u anġjoedema li tista' sseħħ rarament (≥1/10,000 sa <1/1,000), u insuffiċjenza akuta tal-kliewi.
English: • If you are taking an ACE-inhibitor or aliskiren (see also information under the headings “Do not take Micardis” and “Warning and precautions”).
Maltese: • Jekk qed tieħu inibitur ta' ACE jew aliskiren (ara wkoll l-informazzjoni taħt l-intestaturi “Tiħux Micardis” u “Twissijiet u prekawzjonijiet”).
English: Micardis 80 mg tablets EU/1/98/090/005 (14 tablets) EU/1/98/090/006 (28 tablets) EU/1/98/090/007 (56 tablets) EU/1/98/090/008 (98 tablets) EU/1/98/090/014 (28 x 1 tablets) EU/1/98/090/016 (84 tablets) EU/1/98/090/018 (30 x 1 tablets) EU/1/98/090/020 (90 x 1 tablets) EU/1/98/090/022 (4 x (90 x 1) tablets)
Maltese: Micardis 80 mg pilloli EU/1/98/090/005 (14-il pillola) EU/1/98/090/006 (28 pillola) EU/1/98/090/007 (56 pillola) EU/1/98/090/008 (98 pillola) EU/1/98/090/014 (28 x 1 pillola) EU/1/98/090/016 (84 pillola) EU/1/98/090/018 (30 x 1 pillola) EU/1/98/090/020 (90 x 1 pillola) EU/1/98/090/022 (4 x (90 x 1) pilloli)
English: Micardis 40 mg tablets EU/1/98/090/001 (14 tablets) EU/1/98/090/002 (28 tablets) EU/1/98/090/003 (56 tablets) EU/1/98/090/004 (98 tablets) EU/1/98/090/013 (28 x 1 tablets) EU/1/98/090/015 (84 tablets) EU/1/98/090/017 (30 x 1 tablets) EU/1/98/090/019 (90 x 1 tablets) EU/1/98/090/021 (4 x (90 x 1) tablets)
Maltese: Micardis 40 mg pilloli EU/1/98/090/001 (14-il pillola) EU/1/98/090/002 (28 pillola) EU/1/98/090/003 (56 pillola) EU/1/98/090/004 (98 pillola) EU/1/98/090/013 (28 x 1 pillola) EU/1/98/090/015 (84 pillola) EU/1/98/090/017 (30 x 1 pillola) EU/1/98/090/019 (90 x 1 pillola) EU/1/98/090/021 (4 x (90 x 1) pilloli)
English: INFORMATION IN BRAILLE Micardis 20 mg
Maltese: INFORMAZZJONI BIL-BRAILLE Micardis 20 mg
English: INFORMATION IN BRAILLE Micardis 80 mg
Maltese: INFORMAZZJONI BIL-BRAILLE Micardis 80 mg
English: Studies in animals have shown reproductive toxicity (see section 5.3).
Maltese: Studji f'annimali wrew effett tossiku fuq issistema riproduttiva (ara sezzjoni 5.3).
English: Haemoglobin decreased, blood uric acid increased, hepatic enzyme increased, blood creatine phosphokinase increased
Maltese: Tnaqqis fl-emoglobina, żieda fil-uric acid fid-demm, żieda fl-enzimi epatiċi, żieda fil-creatine phosphokinase fid-demm.
English: Telmisartan does not inhibit human plasma renin or block ion channels.
Maltese: Telmisartan ma jinibixxix ir-renina fil-plażma umana jew jimblokka l-kanali taljoni.
English: Telmisartan does not exhibit any partial agonist activity at the AT1 receptor.
Maltese: Telmisartanma jesibixxi l-ebda attività agonista parzjali għar-riċettur AT1.
English: Micardis is contraindicated in patients with severe hepatic impairment (see section 4.3).
Maltese: Micardis hu kontraindikat f'pazjenti b'indeboliment serju tal-fwied (ara sezzjoni 4.3).
English: The concomitant use of Micardis with aliskiren-containing products is contraindicated in patients with diabetes mellitus or renal impairment (GFR < 60 ml/min/1.73 m2) (see sections 4.5 and 5.1).
Maltese: L-użu fl-istess ħin ta' Micardis flimkien ma' prodotti li fihom aliskiren huwa kontraindikat f'pazjenti b'dijabete mellitus jew b'indeboliment tal-kliewi (GFR < 60 ml/min/1.73 m2) (ara sezzjonijiet 4.5 u
English: Micardis 40 mg tablets
Maltese: Micardis 40 mg pilloli
English: EU/1/98/090/009 EU/1/98/090/010 EU/1/98/090/011 EU/1/98/090/012
Maltese: EU/1/98/090/011 EU/1/98/090/012
English: The overall incidence of adverse reactions reported with telmisartan was usually comparable to placebo (41,4% vs 43.9 %) in controlled trials in patients treated for hypertension.
Maltese: L-inċidenza ta' reazzjonijiet avversi rrappurtati kienet ġeneralment komparabbli mal-plaċebo (41.4% vs 43.9%) fil-provi kkontrollati f'pazjenti kkurati għal pressjoni għolja.
English: PHARMACEUTICAL FORM AND CONTENTS Multipack comprising 4 packs, each containing 90 x 1 tablets
Maltese: U KONTENUT Komponent ta' pakkett multiplu li fih 4 pakketti, li kull wieħed fih 90 x 1 pillola.
English: Micardis 40 mg and 80 mg tablets 4 years
Maltese: Micardis 40 mg u 80 mg pilloli 4 snin
English: Micardis may also be used in combination with diuretics ('water tablets') such as hydrochlorothiazide which has been shown to have an additive blood pressure lowering effect with Micardis.
Maltese: Micardis jista' jintuża flimkien ma' dijuretiċi (‘pilloli tal-awrina') bħal hydrochlorothiazide, li ntwera li għandu effett addizzjonali li jnaqqas il-pressjoni tad-demm b'Micardis.
English: Micardis 80 mg tablets
Maltese: Micardis 80 mg pilloli
English: As with other medicinal products acting on the renin-angiotensin-aldosterone system, telmisartan may provoke hyperkalaemia (see section 4.4).
Maltese: Bħal mediċini oħrajn li jaġixxu fuq is-sistema renin-angiotensin-aldosterone, telmisartan jista' jikkawża l-iperkalemija (ara sezzjoni 4.4).
English: Micardis 20 mg tablets
Maltese: Micardis 20 mg pilloli
English: Pack sizes: Blister with 14, 28, 56, 84 or 98 tablets or perforated unit dose blisters with 28 x 1, 30 x 1 or 90 x 1 tablets; multipacks containing 360 (4 packs of 90 x 1) tablets
Maltese: Folja b'14, 28, 56, 84 jew 98 pillola jew folji perforati b'doża waħda bi 28 x 1, 30 x 1 jew 90 x 1 pillola; pakketti multipli li jkun fihom 360 (4 pakketti ta' 90 x 1) pillola
English: Micardis 20 mg tablets 3 years
Maltese: Micardis 20 mg pilloli 3 snin
English: Micardis 20 mg tablets EU/1/98/090/009 (14 tablets) EU/1/98/090/010 (28 tablets) EU/1/98/090/011 (56 tablets) EU/1/98/090/012 (98 tablets)
Maltese: EU/1/98/090/009 (14-il pillola) EU/1/98/090/010 (28 pillola) EU/1/98/090/011 (56 pillola) EU/1/98/090/012 (98 pillola)
English: Micardis is available in blister packs containing 14, 28, 56, 84 or 98 tablets, in unit dose blister packs containing 28 x 1, 30 x 1 or 90 x 1 tablets or in multipacks containing 360 (4 packs of 90 x 1) tablets.
Maltese: Micardis hu disponibbli f'pakketti b'folji ta' 14, 28, 56, 84 jew 98 pillola, f'pakketti bil-folji bid-doża tal-unità li fihom 28 x 1, 30 x 1 jew 90 x 1 pilloli jew f'pakketti multipli li jkun fihom 360 (4 pakketti ta' 90 x 1) pillola.
English: Micardis 40 mg and 80 mg tablets
Maltese: Micardis 40 mg u 80 mg pilloli
English: What Micardis looks like and contents of the pack Micardis 40 mg tablets are white, oblong-shaped, and engraved with the code number '51H' on one side and the company logo on the other side.
Maltese: Il-pilloli Micardis 40 mg huma bojod, b'forma oblunga u mnaqqxa bin-numru tal-kodiċi ‘51H' fuq naħa waħda u bil-logo tal-kumpanija fuq in-naħa l-oħra.
English: EU/1/98/090/001 EU/1/98/090/002 EU/1/98/090/003 EU/1/98/090/004 EU/1/98/090/013 EU/1/98/090/015 EU/1/98/090/017 EU/1/98/090/019
Maltese: EU/1/98/090/001 EU/1/98/090/002 EU/1/98/090/003 EU/1/98/090/004
English: Medicinal products or therapeutic classes of medicinal products that may provoke hyperkalaemia are salt substitutes containing potassium, potassium-sparing diuretics, ACE inhibitors, angiotensin II receptor antagonists, non steroidal anti-inflammatory medicinal products (NSAIDs, including selective COX-2 inhibitors), heparin, immunosuppressives (cyclosporin or tacrolimus), and trimethoprim.
Maltese: Prodotti mediċinali jew klassijiet terapewtiċi ta' prodotti mediċinali li jistgħu jikkawżaw l-iperkalemija huma sostituti tal-melħ li fihom il-potassium, dijuretiċi li ma jneħħux potassium, inibituri ta' ACE, antagonisti tar riċettur ta' angiotensin II, prodotti mediċinali mhux sterojdi kontra l-infjammazzjoni (NSAIDs,li jinkludu inibituri COX-2 selettivi), eparina, immunosoppressuri (cyclosporin jew tacrolimus), u trimethoprim.
English: Prior treatment with high dose diuretics such as furosemide (loop diuretic) and hydrochlorothiazide (thiazide diuretic) may result in volume depletion, and in a risk of hypotension when initiating therapy with telmisartan.
Maltese: Il-kura fil-passat b'dożi qawwija ta' dijuretiċi bħal furosemide (dijuretiku loop) u hydrochlorothiazide (dijuretiku thiazide) tista' tirriżulta fi tnaqqis tal-volum u f'riskju ta' pressjoni tad-demm baxxa ħafna meta tibda t-terapija b'telmisartan.
English: EU/1/98/090/005 EU/1/98/090/006 EU/1/98/090/007 EU/1/98/090/008 EU/1/98/090/014 EU/1/98/090/016 EU/1/98/090/018 EU/1/98/090/020
Maltese: EU/1/98/090/006 EU/1/98/090/007 EU/1/98/090/008 EU/1/98/090/014
English: Concomitant use requiring caution.
Maltese: Rappurtar ta' reazzjonijiet avversi suspettati
English: Boehringer Ingelheim RCV GmbH & Co KG Latvijas filiāle Tel: +371 67 240 011
Maltese: KG Latvijas filiāle Tel: +371 67 240 011
English: At the beginning of the preventive therapy with Micardis 80 mg, blood pressure should be frequently monitored.
Maltese: Fil-bidu tat-terapija preventiva b'Micardis 80mg, il-pressjoni tad-demm għandha tiġi mmonitorjata ta' spiss.